Mereo BioPharma Group (Mereo BioPharma Group) Days Sales Outstanding : 1,800.58 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Mereo BioPharma Group Days Sales Outstanding?

Mereo BioPharma Group's average Accounts Receivable for the six months ended in Dec. 2023 was $9.96 Mil. Mereo BioPharma Group's Revenue for the six months ended in Dec. 2023 was $1.01 Mil. Hence, Mereo BioPharma Group's Days Sales Outstanding for the six months ended in Dec. 2023 was 1,800.58.

The historical rank and industry rank for Mereo BioPharma Group's Days Sales Outstanding or its related term are showing as below:

MREO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0 Med: 0 Max: 363.36
Current: 363.36

During the past 9 years, Mereo BioPharma Group's highest Days Sales Outstanding was 363.36. The lowest was 0.00. And the median was 0.00.

MREO's Days Sales Outstanding is ranked worse than
90.44% of 889 companies
in the Biotechnology industry
Industry Median: 71.83 vs MREO: 363.36

Mereo BioPharma Group's Days Sales Outstanding increased from Dec. 2022 (0.00) to Dec. 2023 (1,800.58).

Mereo BioPharma Group Days Sales Outstanding Historical Data

The historical data trend for Mereo BioPharma Group's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mereo BioPharma Group Days Sales Outstanding Chart

Mereo BioPharma Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

Mereo BioPharma Group Semi-Annual Data
	Jun15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial												-	-	-	202.07	1,800.58

Competitive Comparison of Mereo BioPharma Group's Days Sales Outstanding

For the Biotechnology subindustry, Mereo BioPharma Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mereo BioPharma Group's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mereo BioPharma Group's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Mereo BioPharma Group's Days Sales Outstanding falls into.

Mereo BioPharma Group Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Mereo BioPharma Group's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	10	*	365
=	0					/	10	*	365
=	0.00

Mereo BioPharma Group's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (9.955	+	0)	/	1 )	/	1.009	*	365 / 2
=	9.955					/	1.009	*	365 / 2
=	1,800.58

Mereo BioPharma Group (NAS:MREO) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Mereo BioPharma Group Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Mereo BioPharma Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Mereo BioPharma Group (Mereo BioPharma Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mereo BioPharma Group PLC (NAS:MREO) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

MAH0:Germany MAH0:Germany

Address

One Cavendish Place, 4th Floor, London, GBR, W1G 0QF

Website

https://www.mereobiopharma.com

Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its oncology product candidate is etigilimab, for patients with solid tumors. Some of the other products in the pipeline are setrusumab, alvelestat, leflutrozole, navicixizumab, and acumapimod.